Dorraya El‐Ashry

4.1k total citations
52 papers, 3.1k citations indexed

About

Dorraya El‐Ashry is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Dorraya El‐Ashry has authored 52 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 31 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Dorraya El‐Ashry's work include Cancer Cells and Metastasis (17 papers), Estrogen and related hormone effects (14 papers) and HER2/EGFR in Cancer Research (12 papers). Dorraya El‐Ashry is often cited by papers focused on Cancer Cells and Metastasis (17 papers), Estrogen and related hormone effects (14 papers) and HER2/EGFR in Cancer Research (12 papers). Dorraya El‐Ashry collaborates with scholars based in United States, United Kingdom and Spain. Dorraya El‐Ashry's co-authors include Florian Kern, Marc E. Lippman, Gabriela Dontu, Max S. Wicha, Joyce M. Slingerland, Chad J. Creighton, David L. Miller, Jamie N. Holloway, Shalini Murthy and Katherine Drews‐Elger and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Dorraya El‐Ashry

51 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorraya El‐Ashry United States 31 1.7k 1.7k 972 789 334 52 3.1k
J. Chuck Harrell United States 35 1.9k 1.1× 1.8k 1.1× 1.1k 1.2× 668 0.8× 302 0.9× 78 3.6k
Michele De Bortoli Italy 32 2.0k 1.1× 1.0k 0.6× 808 0.8× 614 0.8× 522 1.6× 97 3.2k
S. G. Hilsenbeck United States 10 1.2k 0.7× 1.5k 0.9× 703 0.7× 580 0.7× 136 0.4× 16 2.4k
Maximilian Reichert Germany 26 1.8k 1.0× 2.2k 1.3× 897 0.9× 356 0.5× 368 1.1× 58 3.6k
François X. Claret United States 30 1.9k 1.1× 1.0k 0.6× 599 0.6× 251 0.3× 388 1.2× 52 2.8k
Soner Altiok United States 27 2.1k 1.2× 1.3k 0.8× 646 0.7× 250 0.3× 758 2.3× 60 3.5k
Fariba Behbod United States 26 1.6k 0.9× 1.8k 1.1× 715 0.7× 190 0.2× 505 1.5× 62 3.1k
Rui‐An Wang United States 29 2.2k 1.3× 1.1k 0.7× 604 0.6× 720 0.9× 213 0.6× 56 3.1k
Patricia V. Elizalde Argentina 28 1.1k 0.6× 1.0k 0.6× 478 0.5× 489 0.6× 317 0.9× 60 2.1k
Sizhi Paul Gao United States 20 1.1k 0.7× 1.1k 0.7× 576 0.6× 275 0.3× 284 0.9× 32 2.3k

Countries citing papers authored by Dorraya El‐Ashry

Since Specialization
Citations

This map shows the geographic impact of Dorraya El‐Ashry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorraya El‐Ashry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorraya El‐Ashry more than expected).

Fields of papers citing papers by Dorraya El‐Ashry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorraya El‐Ashry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorraya El‐Ashry. The network helps show where Dorraya El‐Ashry may publish in the future.

Co-authorship network of co-authors of Dorraya El‐Ashry

This figure shows the co-authorship network connecting the top 25 collaborators of Dorraya El‐Ashry. A scholar is included among the top collaborators of Dorraya El‐Ashry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorraya El‐Ashry. Dorraya El‐Ashry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ziegler, Yvonne, Mary J. Laws, Valeria Sanabria Guillen, et al.. (2019). Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds. npj Breast Cancer. 5(1). 45–45. 62 indexed citations
2.
Jang, Keum‐Il, Philip Miller, Manuel Picon‐Ruiz, et al.. (2017). VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug. Oncogene. 36(36). 5199–5211. 81 indexed citations
3.
Picon‐Ruiz, Manuel, Katherine Drews‐Elger, Kibeom Jang, et al.. (2016). Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression. Cancer Research. 76(2). 491–504. 143 indexed citations
4.
Miller, Philip C., Dorraya El‐Ashry, Jun Sun, et al.. (2015). MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 22(4). 935–947. 46 indexed citations
5.
6.
Miller, Philip C., Jennifer Clarke, Tulay Koru‐Sengul, Joeli Brinkman, & Dorraya El‐Ashry. (2014). A Novel MAPK–microRNA Signature Is Predictive of Hormone-Therapy Resistance and Poor Outcome in ER-Positive Breast Cancer. Clinical Cancer Research. 21(2). 373–385. 37 indexed citations
7.
Drews‐Elger, Katherine, Joeli Brinkman, Philip Miller, et al.. (2014). Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures. Breast Cancer Research and Treatment. 144(3). 503–517. 31 indexed citations
8.
Zhao, Dekuang, Junjun Sun, Candace A. Gilbert, et al.. (2014). VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Oncogene. 34(24). 3107–3119. 219 indexed citations
9.
Cuiffo, Benjamin, Antoine Campagne, George W. Bell, et al.. (2014). MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis. Cell stem cell. 15(6). 762–774. 143 indexed citations
10.
Hnatyszyn, H. James, Lynn M. Herbert, Carmen Gomez‐Fernandez, et al.. (2009). Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody. Breast Cancer Research and Treatment. 122(2). 371–380. 21 indexed citations
11.
Brinkman, Joeli & Dorraya El‐Ashry. (2009). ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers. Journal of Mammary Gland Biology and Neoplasia. 14(1). 67–78. 52 indexed citations
12.
Marshall, John L., Michael D. Johnson, John Hanfelt, et al.. (2004). A Phase II Trial of ISIS 3521 in Patients with Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 4(4). 268–274. 28 indexed citations
13.
Dougherty, M. K., Lisa M. Schumaker, V. Craig Jordan, et al.. (2004). Estrogen Receptor Expression and Sensitivity to Paclitaxel in Breast Cancer. Cancer Biology & Therapy. 3(5). 460–467. 20 indexed citations
14.
Dontu, Gabriela, Dorraya El‐Ashry, & Max S. Wicha. (2004). Breast cancer, stem/progenitor cells and the estrogen receptor. Trends in Endocrinology and Metabolism. 15(5). 193–197. 233 indexed citations
15.
Clarke, Robert, Todd C. Skaar, Dorraya El‐Ashry, Fabio Leonessa, & Leena Hilakivi‐Clarke. (1999). Use of ERE and Reporter Gene Constructs to Assess Putative Estrogenic Activity. Journal of Medicinal Food. 2(3-4). 143–149.
16.
Nass, Sharyl J., Anne Ferguson, Dorraya El‐Ashry, William G. Nelson, & Nancy E. Davidson. (1999). Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. Oncogene. 18(52). 7453–7461. 33 indexed citations
17.
El‐Ashry, Dorraya, David L. Miller, Samir Kharbanda, Marc E. Lippman, & Florian Kern. (1997). Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis. Oncogene. 15(4). 423–435. 83 indexed citations
18.
El‐Ashry, Dorraya, Susan A. Chrysogelos, Marc E. Lippman, & Florian Kern. (1996). Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes. The Journal of Steroid Biochemistry and Molecular Biology. 59(3-4). 261–269. 58 indexed citations
19.
Kühnel, B., Dorraya El‐Ashry, Dean P. Edwards, & Steven K. Nordeen. (1989). Mapping Contacts between Unpurified Human Progesterone Receptor and the Hormone Response Element of Mouse Mammary Tumor Virus. DNA. 8(10). 703–713. 4 indexed citations
20.
El‐Ashry, Dorraya, Sergio A. Oñate, Steven K. Nordeen, & Dean P. Edwards. (1989). Human Progesterone Receptor Complexed with the Antagonist RU 486 Binds to Hormone Response Elements in a Structurally Altered Form. Molecular Endocrinology. 3(10). 1545–1558. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Chuck Harrell Breakdown of academic impact, for papers by Michele De Bortoli Breakdown of academic impact, for papers by S. G. Hilsenbeck Breakdown of academic impact, for papers by Maximilian Reichert Breakdown of academic impact, for papers by François X. Claret Breakdown of academic impact, for papers by Soner Altiok Breakdown of academic impact, for papers by Fariba Behbod Breakdown of academic impact, for papers by Rui‐An Wang Breakdown of academic impact, for papers by Patricia V. Elizalde Breakdown of academic impact, for papers by Sizhi Paul Gao
Rankless by CCL
2026